Monopar Therapeutics (MNPR)
(Delayed Data from NSDQ)
$5.17 USD
+0.76 (17.23%)
Updated Sep 25, 2024 04:00 PM ET
After-Market: $5.17 0.00 (0.00%) 7:58 PM ET
4-Sell of 5 4
F Value C Growth F Momentum F VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 11/14/24 |
---|---|
Current Quarter | -0.46 |
EPS Last Quarter | -0.50 |
Last EPS Surprise | -11.11% |
ABR | 1.00 |
Earnings ESP
|
0.00% |
---|---|
Current Year | -1.93 |
Next Year | -1.82 |
EPS (TTM) | -2.30 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | NA | NA | NA | NA |
# of Estimates | NA | NA | NA | NA |
High Estimate | NA | NA | NA | NA |
Low Estimate | NA | NA | NA | NA |
Year ago Sales | 0.00M | 0.00M | NA | NA |
Year over Year Growth Est. | NA | NA | NA | NA |
Earnings Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.46 | -0.48 | -1.93 | -1.82 |
# of Estimates | 2 | 2 | 2 | 1 |
Most Recent Consensus | -0.52 | -0.41 | -2.06 | -1.82 |
High Estimate | -0.40 | -0.41 | -1.80 | -1.82 |
Low Estimate | -0.52 | -0.54 | -2.06 | -1.82 |
Year ago EPS | -0.70 | -0.60 | -3.05 | -1.93 |
Year over Year Growth Est. | 34.29% | 20.00% | 36.72% | 5.70% |
Agreement - Estimate Revisions
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 0 |
Up Last 60 Days | 1 | 0 | 0 | 0 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 1 | 2 | 2 | 1 |
Magnitude - Consensus Estimate Trend
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.46 | -0.48 | -1.93 | -1.82 |
7 Days Ago | -0.46 | -0.48 | -1.93 | -1.82 |
30 Days Ago | -0.46 | -0.48 | -1.93 | -1.82 |
60 Days Ago | -0.48 | -0.43 | -1.83 | -1.75 |
90 Days Ago | -0.48 | -0.43 | -1.83 | -1.75 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.46 | -0.48 | -1.93 | -1.82 |
Zacks Consensus Estimate | -0.46 | -0.48 | -1.93 | -1.82 |
Earnings ESP | 0.00% | 0.00% | 0.00% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (6/2024) |
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.50 | -0.50 | -0.60 | -0.70 | NA |
Estimate | -0.45 | -0.85 | -0.85 | -0.95 | NA |
Difference | -0.05 | 0.35 | 0.25 | 0.25 | 0.20 |
Surprise | -11.11% | 41.18% | 29.41% | 26.32% | 21.45% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more